Clinical markers for identifying cholinergic deficits in Parkinson's disease

Cholinergic projection systems degeneration is associated with dopamine nonresponsive features of Parkinson's disease (PD). Cholinergic deficits are variable in nondemented PD. Identification of cholinergic deficits in PD may help with selection of suitable patients for targeted cholinergic drug treatment in PD. The objective of this retrospective multivariate predictor analysis study was to identify clinical markers indicative of cholinergic deficits in PD patients, as assessed by acetylcholinesterase ([11C]PMP) positron emission tomography.

[1]  R. Albin,et al.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease , 2010, Brain : a journal of neurology.

[2]  R. Albin,et al.  Gender differences in cholinergic and dopaminergic deficits in Parkinson disease , 2013, Journal of Neural Transmission.

[3]  D. Burn,et al.  The interplay of cholinergic function, attention, and falls in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[4]  W. Poewe,et al.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[5]  Robert A Koeppe,et al.  Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. , 2013, Brain : a journal of neurology.

[6]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[7]  F. Horak,et al.  Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease , 2010, Neurology.

[8]  R. Albin,et al.  β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia , 2013, Movement disorders : official journal of the Movement Disorder Society.

[9]  B. Bloem,et al.  Postural instability in Parkinson’s disease: the adrenergic hypothesis and the locus coeruleus , 2009, Expert review of neurotherapeutics.

[10]  Paul Shaman,et al.  University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic , 1984, The Laryngoscope.

[11]  R. Mehanna.  Gait speed in Parkinson disease correlates with cholinergic degeneration , 2014, Neurology.

[12]  Hitoshi Shinotoh,et al.  Kinetic Analysis of [11C]MP4A Using a High-Radioactivity Brain Region That Represents an Integrated Input Function for Measurement of Cerebral Acetylcholinesterase Activity without Arterial Blood Sampling , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  R. Albin,et al.  Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease , 2014, Neurology.

[14]  Peter J. H. Scott,et al.  Highlighting the versatility of the Tracerlab synthesis modules. Part 2: fully automated production of [11C]-labeled radiopharmaceuticals using a Tracerlab FXC-Pro: Production of [11C] radiopharmaceuticals using a Tracerlab FXC-Pro , 2011 .

[15]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[16]  S. Studenski,et al.  History of falls in Parkinson disease is associated with reduced cholinergic activity , 2009, Neurology.

[17]  J. Langston,et al.  The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.

[18]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[19]  N. Bohnen,et al.  Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.

[20]  Y H Sohn,et al.  The influence of white matter hyperintensities on the clinical features of Parkinson's disease. , 1998, Yonsei medical journal.

[21]  P. Svenningsson,et al.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment , 2012, The Lancet Neurology.

[22]  R. Doty,et al.  Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.

[23]  Ronald C Petersen,et al.  Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. , 2011, Sleep medicine.

[24]  D. Yang,et al.  Influence of White Matter Hyperintensities on the Cognition of Patients With Parkinson Disease , 2010, Alzheimer disease and associated disorders.

[25]  N. Bohnen,et al.  In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease , 2013, Journal of Neural Transmission.

[26]  N. Bohnen,et al.  Positron Emission Tomography of Monoaminergic Vesicular Binding in Aging and Parkinson Disease , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  F Lhermitte,et al.  Cholinergic‐dependent cognitive deficits in Parkinson's disease , 1987, Annals of neurology.

[28]  S. Gilman,et al.  Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Martijn L T M Müller,et al.  Cholinergic Dysfunction in Parkinson’s Disease , 2013, Current Neurology and Neuroscience Reports.

[30]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[31]  R. Chervin,et al.  Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease , 2012, Annals of neurology.

[32]  R. Albin,et al.  Diabetes is associated with postural instability and gait difficulty in Parkinson disease. , 2013, Parkinsonism & related disorders.